Open access · US-GOV via ClinicalTrials.gov Clinical trial

The Role of the Muscle-nervous System Interface in Cancer Cachexia

Authors not listed

University of Roma La Sapienza · 2018

Altered intercellular communication Human Randomized controlled trial

Abstract

Sarcopenia is an important component of cachexia associated with cancer, and their high incidence in cancer patients emphasizes the need for a better understanding of its mechanisms, which can result in better therapeutic interventions to reverse this situation and improve the prognosis. Our hypothesis is that the plasma concentration of IL-6 and c-terminal agrin is directly correlated with the loss of muscle mass and development of cachexia.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-18 MST

Cite this

APA

Anonymous. (2018). The Role of the Muscle-nervous System Interface in Cancer Cachexia. <em>University of Roma La Sapienza</em>. https://clinicaltrials.gov/study/NCT03477721

Vancouver

Anonymous. The Role of the Muscle-nervous System Interface in Cancer Cachexia. University of Roma La Sapienza. 2018.

BibTeX

@misc{anon2018TheRol, title = {The Role of the Muscle-nervous System Interface in Cancer Cachexia}, author = {Anonymous}, journal = {University of Roma La Sapienza}, year = {2018}, }